🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Upper tract urothelial ca - the 'Queen' has spoken - role of adjuvant Platinum based chemo in high-risk pathology, no role of immunotherapy in adjuvant setting at this moment & potential prognostic ctDNA in the future #EAU2025 💙alison birtle

Thought provoking start - role of ctDNA in de-escalating treatment and follow up in nmMIBC - no neoadjuvant treatment and less follow up? Exciting times ahead #EAU25 Dr. John Sfakianos

Good reminder of shared decision making is the cornerstone in our clinical practice! Not just a lip service. Powerful message from patient's stories! #EAU25 💙alison birtle

Good debate. Share decision in selected patient of excellent responders in mHSPC. No strong evidence to stop but current evidence does not capture the long term follow up. Session ended with great comment by Christopher Sweeney, MBBS Gustave Roussy Omar El-Taji tombal

Patients should be getting the right treatment based on their condition, not postcode. More work to be done locally for better care 💙alison birtle #EAU2025

In a world where healthcare is often limited by financial constraints, making radiotherapy accessible is a quick win👊 —and frankly, a no-brainer. Thank you prof. Barbara Jereczek-Fossa for highlighting this at #EAU25

Huge congratulations to Robin Dolgos and Clémentine Le Magnen on winning Best Oncology Abstract at #EAU25! A brilliant example of rigorous lab work with real potential for clinical impact. Well deserved 👏

What a bonkers decision:’ Ridiculous’ cuts to AI cancer tech funding in England could cost lives, experts warn theguardian.com/politics/2025/…

Bladder preservation is a philosophy—not just a protocol. A 15-year journey in bladder preservation at TMC Radiation Oncology . Tata Memorial Hospital ACTREC-TMC From pioneering Adaptive Radiotherapy (ART) to safely transitioning to hypofractionation, our story, in IJROBP - The Red Journal #RadOnc #bladdercancer

Turning genetic insight into real-world impac. Prostate cancer screening is getting smarter, faster, and fairer. Policy needs to keep pace nejm.org/doi/full/10.10…

A new @UroToday commentary builds on our meta-analysis of peripheral vs transition zone prostate cancer, examining outcomes and highlighting research gaps. 🧠 For those interested in prostate tumour zonal biology. 🔗 urotoday.com/recent-abstrac…... Prof Ananya💙 @achoud72.bsky.social BMJ Oncology

Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4dVJAU8